APA (7th ed.) Citation

Zhao, L., Huang, C., Zheng, R., Zhou, H., Chen, G., Ye, Y., . . . Li, S. (2025). Cu2+‐Coordinated NLG919: A Drug Delivery Nanoplatform to Activate Antitumor Immunity via Inducing Immunogenic Cell Death and Inhibiting Indoleamine 2,3‐Dioxygenase‐1. Medcomm: Biomaterials & Applications, 4(3), 1. https://doi.org/10.1002/mba2.70024

Chicago Style (17th ed.) Citation

Zhao, Lin‐Ping, Chu‐Yu Huang, Rong‐Rong Zheng, Hang‐Yu Zhou, Guang‐Miao Chen, Yun Ye, Ying‐Ling Miao, and Shi‐Ying Li. "Cu2+‐Coordinated NLG919: A Drug Delivery Nanoplatform to Activate Antitumor Immunity via Inducing Immunogenic Cell Death and Inhibiting Indoleamine 2,3‐Dioxygenase‐1." Medcomm: Biomaterials & Applications 4, no. 3 (2025): 1. https://doi.org/10.1002/mba2.70024.

MLA (9th ed.) Citation

Zhao, Lin‐Ping, et al. "Cu2+‐Coordinated NLG919: A Drug Delivery Nanoplatform to Activate Antitumor Immunity via Inducing Immunogenic Cell Death and Inhibiting Indoleamine 2,3‐Dioxygenase‐1." Medcomm: Biomaterials & Applications, vol. 4, no. 3, 2025, p. 1, https://doi.org/10.1002/mba2.70024.